NeuroAge Therapeutics
NeuroAge Therapeutics is a biotech startup focused on reversing brain aging and combating neurodegenerative disorders like Alzheimer's. They utilize AI and personalized biomarkers, including cognitive testing, blood analysis, genetics, and MRI, to identify targets for treatments that address the aging process itself rather than just late-stage symptoms. Their approach involves identifying genes associated with slower brain aging, designing drugs based on these genes, and validating them through clinical trials. The company aims to create tailored therapeutics by understanding individual brain health markers and genetic profiles to prevent and treat age-related neurodegenerative diseases.
NeuroAge Therapeutics
NeuroAge Therapeutics is a biotech startup focused on reversing brain aging and combating neurodegenerative disorders like Alzheimer's. They utilize AI and personalized biomarkers, including cognitive testing, blood analysis, genetics, and MRI, to identify targets for treatments that address the aging process itself rather than just late-stage symptoms. Their approach involves identifying genes associated with slower brain aging, designing drugs based on these genes, and validating them through clinical trials. The company aims to create tailored therapeutics by understanding individual brain health markers and genetic profiles to prevent and treat age-related neurodegenerative diseases.
